Literature DB >> 27008069

Treatment satisfaction with different weight loss methods among respondents with obesity.

S Gupta1, Z Wang2.   

Abstract

Satisfaction with weight loss (WL) methods has been correlated with the effectiveness, long-term compliance and commitment to weight management. This study explored treatment satisfaction associated with different WL methods among patients with obesity. Cross-sectional data were analysed from the 2012 US National Health and Wellness Survey. Respondents with obesity were categorized as having a WL procedure (e.g., gastric bypass and gastric banding) or using a prescription medication for WL (Sur/Rx), vs. using self-modification WL techniques (e.g., diet, exercise and WL supplements). Overall satisfaction with current WL methods was assessed among the obese and the overweight/obese with type 2 diabetes mellitus (T2DM). Of the 22 927 respondents with obesity, 58.4% took no current action to lose weight, 2.3% were identified as Sur/Rx and 39.3% were identified as self-modification. The Sur/Rx group reported being very/extremely satisfied more frequently than the self-modification group (39.3% vs. 20.2%, P < 0.001). Similarly, respondents with T2DM that were overweight/obese reported higher satisfaction in the Sur/Rx vs. the self-modification group (46.6% vs. 22.7%, P < 0.001). Satisfaction with WL methods was greater for the Sur/Rx vs. the self-modification group. Data suggest the importance of including bariatric surgery and pharmacotherapy as an integral part in comprehensive WL management.
© 2016 World Obesity.

Entities:  

Keywords:  Body mass index; type 2 diabetes; weight loss medication; weight loss satisfaction

Mesh:

Substances:

Year:  2016        PMID: 27008069     DOI: 10.1111/cob.12140

Source DB:  PubMed          Journal:  Clin Obes        ISSN: 1758-8103


  7 in total

1.  Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015.

Authors:  David R Saxon; Sean J Iwamoto; Christie J Mettenbrink; Emily McCormick; David Arterburn; Matthew F Daley; Caryn E Oshiro; Corinna Koebnick; Michael Horberg; Deborah R Young; Daniel H Bessesen
Journal:  Obesity (Silver Spring)       Date:  2019-10-11       Impact factor: 5.002

2.  Finger Citron Extract Ameliorates Glycolipid Metabolism and Inflammation by Regulating GLP-1 Secretion via TGR5 Receptors in Obese Rats.

Authors:  Yujiao Yang; Aofei Tian; Zhen Wu; Yao Wei; Xuguang Hu; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-27       Impact factor: 2.629

Review 3.  Dietary capsaicin and its anti-obesity potency: from mechanism to clinical implications.

Authors:  Jia Zheng; Sheng Zheng; Qianyun Feng; Qian Zhang; Xinhua Xiao
Journal:  Biosci Rep       Date:  2017-05-11       Impact factor: 3.840

4.  Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience.

Authors:  Flavio A Cadegiani; Gustavo C Diniz; Gabriella Alves
Journal:  BMC Obes       Date:  2017-02-21

5.  Validation of the Diet Satisfaction Questionnaire: a new measure of satisfaction with diets for weight management.

Authors:  B L James; E Loken; L S Roe; K Myrissa; C L Lawton; L Dye; B J Rolls
Journal:  Obes Sci Pract       Date:  2018-10-10

6.  A Combination of Lactoplantibacillus plantarum Strains CECT7527, CECT7528, and CECT7529 Plus Monacolin K Reduces Blood Cholesterol: Results from a Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Rafael Guerrero-Bonmatty; Guadalupe Gil-Fernández; Francisco José Rodríguez-Velasco; Jordi Espadaler-Mazo
Journal:  Nutrients       Date:  2021-04-06       Impact factor: 5.717

7.  Early predictors of weight loss in a 1-year behavioural weight-loss programme.

Authors:  B L James; L S Roe; E Loken; B J Rolls
Journal:  Obes Sci Pract       Date:  2018-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.